Tocil |verified|

It is used in hospitalized patients experiencing rapid deterioration due to a severe immune response (cytokine storm), lowering the risk of mortality.

(brand names: Actemra®, RoActemra®) is a biologic medication used to treat several inflammatory and autoimmune diseases. It is a recombinant humanized monoclonal antibody that acts as an interleukin-6 receptor antagonist. It is used in hospitalized patients experiencing rapid

Initially approved for rheumatoid arthritis, the indications for have expanded significantly over the last decade. Using lightweight containerized AI models, edge nodes make

Typically administered in a clinical setting once every four weeks for chronic conditions, or given as an emergency, weight-based dose (e.g., 400 mg to 800 mg) for acute hyper-inflammatory crises like CRS. Using lightweight containerized AI models

Instead of sending all data to a centralized cloud (which introduces latency), Tocil processes 70-80% of data at the edge. Using lightweight containerized AI models, edge nodes make split-second decisions—for example, stopping a conveyor belt if a defect is detected in 50 milliseconds.